Here’s Why Diamond Hill Mid Cap Composite Purchased Revvity (RVTY) in Q3

Here’s Why Diamond Hill Mid Cap Composite Purchased Revvity (RVTY) in Q3


Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Markets continued their rally in the third quarter, with US stocks gaining over 8% as measured by the Russell 3000 Index. Small-cap stocks experienced the strongest quarterly performance, rising by more than 12%, whereas large-cap stocks increased by about 8%, and mid-cap stocks saw a gain of 5%. The strategy underperformed the Russell Midcap Index in the third quarter, returning 4.49% net vs. 5.33% for the Index. For more information on the fund’s top picks in 2025, please check its top five holdings.

In its third-quarter 2025 investor letter, Diamond Hill Mid Cap Strategy highlighted stocks such as Revvity, Inc. (NYSE:RVTY). Revvity, Inc. (NYSE:RVTY) is a health sciences solutions, technologies, and services company. The one-month return for Revvity, Inc. (NYSE:RVTY) was -5.16%, and its shares lost 12.70% over the last 52 weeks. On December 30, 2025, Revvity, Inc. (NYSE:RVTY) stock closed at $97.43 per share, with a market capitalization of $11.309 billion.

Diamond Hill Mid Cap Strategy stated the following regarding Revvity, Inc. (NYSE:RVTY) in its third quarter 2025 investor letter:

“Though markets have continued rising throughout the year, we have continued finding individual companies whose prices we believe are not reflective of their long-term growth outlooks. Accordingly, we initiated several new positions in Q3, including Toro Company, Equitable Holdings, Cooper Companies and Revvity, Inc. (NYSE:RVTY).

Revvity, Inc. (NYSE:RVTY) is not on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 22 hedge fund portfolios held Revvity, Inc. (NYSE:RVTY) at the end of the third quarter, compared to 27 in the previous quarter. In Q3 2025, Revvity, Inc. (NYSE:RVTY) reported revenue of $699 million, resulting in 1% organic growth. While we acknowledge the potential of Revvity, Inc. (NYSE:RVTY) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.


finance.yahoo.com
#Heres #Diamond #Hill #Mid #Cap #Composite #Purchased #Revvity #RVTY

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *